Literature DB >> 18159905

Bullous pemphigoid: physiopathology, clinical features and management.

Giovanni Di Zenzo1, Gionata Marazza, Luca Borradori.   

Abstract

There has been a considerable progress in the understanding of the physiopathology of BP during the past 2 decades. The insights into the humoral and cellular immune response against BP180 and BP230 have increased significantly. Nevertheless, the factors underlying the initiation of the disease leading to a disruption of self-tolerance remain unclear. Clinically, the disease shows protean presentations, and diagnostic delay is common. A practical, relevant, and unresolved question is how to identify patients suffering from BP at an early stage of the disease, when direct immunofluorescence microscopy findings still may be negative. The characterization of markers allowing the differentiation of BP from other pruritic eruptions occurring in the elderly population would be extremely helpful in daily practice. Finally, despite the knowledge that potent topical steroids are efficient in controlling the disease, management of BP sometimes remains difficult and requires systemic therapies. It is hoped that a better knowledge of the regulation of the autoimmune response in BP also will facilitate the design of novel immunomodulatory therapeutic approaches devoid of the severe side effects of current immunosuppressive treatments.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18159905     DOI: 10.1016/j.yadr.2007.07.013

Source DB:  PubMed          Journal:  Adv Dermatol        ISSN: 0882-0880


  15 in total

Review 1.  Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract.

Authors:  Dagmar Simon; Andrew Wardlaw; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2010-04-14       Impact factor: 10.793

Review 2.  High-dose intravenous immunoglobulin (IVIG) therapy in autoimmune skin blistering diseases.

Authors:  Norito Ishii; Takashi Hashimoto; Detlef Zillikens; Ralf J Ludwig
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

3.  Case Report of Bullous Pemphigoid following Fundus Fluorescein Angiography.

Authors:  Goktug Demirci; Gulsen Tukenmez Demirci; Gokhan Gulkilik
Journal:  Case Rep Ophthalmol       Date:  2010-05-12

4.  Dapsone-responsive inflammatory dermatitis with features of subcorneal pustular dermatosis and bullous pemphigoid.

Authors:  Shilpa Ghatnekar; Audrey Rutherford; Travis Vandergriff; Kim B Yancey
Journal:  JAAD Case Rep       Date:  2022-02-03

5.  Pathophysiology of Autoimmune Bullous Diseases: Nature Versus Nurture.

Authors:  Forum Patel; Reason Wilken; Falin B Patel; Hawa Sultani; Itzel Bustos; Christopher Duong; John J Zone; Siba P Raychaudhuri; Emanual Maverakis
Journal:  Indian J Dermatol       Date:  2017 May-Jun       Impact factor: 1.494

6.  Dysregulation of mCD46 and sCD46 contribute to the pathogenesis of bullous pemphigoid.

Authors:  Pei Qiao; Erle Dang; Tianyu Cao; Hui Fang; Jieyu Zhang; Hongjiang Qiao; Gang Wang
Journal:  Sci Rep       Date:  2017-03-10       Impact factor: 4.379

7.  Mucosal Involvement in Bullous Pemphigoid Is Mostly Associated with Disease Severity and to Absence of Anti-BP230 Autoantibody.

Authors:  Ariane Clapé; Céline Muller; Grégory Gatouillat; Sébastien Le Jan; Coralie Barbe; Bach-Nga Pham; Frank Antonicelli; Philippe Bernard
Journal:  Front Immunol       Date:  2018-03-13       Impact factor: 7.561

8.  Decreased expression levels of complement regulator CD55 contribute to the development of bullous pemphigoid.

Authors:  Pei Qiao; Er-Le Dang; Hui Fang; Jie-Yu Zhang; Bing Li; Sheng-Xian Shen; Yi-Xin Luo; Jie Lei; Shuai Shao; Hong-Jiang Qiao; Gang Wang
Journal:  Oncotarget       Date:  2017-09-23

9.  May Bacterial Infections Trigger Bullous Pemphigoid? Case Report and Review of Literature.

Authors:  Michela Ileen Biondo; Chiara Fiorentino; Severino Persechino; Antonella Tammaro; Angela Koverech; Armando Bartolazzi; Salvatore Raffa; Marco Canzoni; Andrea Picchianti-Diamanti; Roberta Di Rosa; Giovanni Di Zenzo; Enrico Scala; Giorgia Meneguzzi; Claudia Ferlito; Milica Markovic; Sara Caporuscio; Maria Laura Sorgi; Simonetta Salemi; Bruno Laganà
Journal:  Microorganisms       Date:  2021-06-07

10.  Mortality and Comorbidity Profiles of Patients with Bullous Pemphigoid in Korea.

Authors:  Hyeon Woo Jeon; Sook Jung Yun; Seung-Chul Lee; Young Ho Won; Jee-Bum Lee
Journal:  Ann Dermatol       Date:  2017-12-26       Impact factor: 1.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.